Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-65,248
Closed -$15.4M 414
2020
Q2
$15.4M Buy
65,248
+11,099
+20% +$2.53M 0.75% 31
2020
Q1
$11M Buy
54,149
+225
+0.4% +$49.1K 0.62% 47
2019
Q4
$13M Sell
53,924
-16,461
-23% -$3.63M 0.49% 68
2019
Q3
$13.6M Sell
70,385
-27,420
-28% -$5.26M 0.56% 55
2019
Q2
$18M Buy
97,805
+550
+0.6% +$98.5K 0.71% 35
2019
Q1
$18.5M Buy
97,255
+525
+0.5% +$100K 0.74% 29
2018
Q4
$18.8M Buy
96,730
+2,950
+3% +$576K 0.85% 17
2018
Q3
$19.4M Buy
93,780
+4,825
+5% +$951K 0.74% 22
2018
Q2
$16.4M Sell
88,955
-26,865
-23% -$4.75M 0.67% 26
2018
Q1
$19.7M Buy
115,820
+31,390
+37% +$5.76M 0.84% 14
2017
Q4
$14.7M Sell
84,430
-4,350
-5% -$770K 0.61% 42
2017
Q3
$16.6M Sell
88,780
-1,640
-2% -$291K 0.66% 26
2017
Q2
$15.6M Buy
90,420
+18,375
+26% +$2.99M 0.64% 28
2017
Q1
$11.8M Sell
72,045
-6,910
-9% -$1.15M 0.49% 55
2016
Q4
$11.5M Sell
78,955
-2,625
-3% -$395K 0.5% 51
2016
Q3
$13.6M Buy
81,580
+25,795
+46% +$4.36M 0.72% 24
2016
Q2
$8.49M Buy
+55,785
New +$8.67M 0.48% 74
2014
Q3
Sell
-24,095
Closed -$2.85M 250
2014
Q2
$2.85M Sell
24,095
-398
-2% -$46.1K 0.26% 102
2014
Q1
$3.02M Sell
24,493
-1,098
-4% -$133K 0.28% 108
2013
Q4
$2.92M Buy
+25,591
New +$2.91M 0.26% 114

Other funds holding AMGN

Foundry Partners's AMGN Position: Q3 2020 in Review

Foundry Partners sold out of Amgen (AMGN) in Q3 2020, closing a stake of 65,248 shares — an estimated $15.4M sold.

Foundry Partners first reported a position in AMGN in Q4 2013 and held it in 20 quarters. The position peaked at $19.7M in Q1 2018. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Foundry Partners reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
  • Foundry Partners sold 65,248 Amgen shares in Q3 2020, an estimated $15.4M.
  • Foundry Partners first reported a position in Amgen in Q4 2013 and held it in 20 quarters.
  • Foundry Partners's Amgen position peaked at $19.7M in Q1 2018.
  • 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Foundry Partners's 13F filing for Q3 2020, filed 23 Oct 2020.